Our areas of expertise
▸ Diagnosis of difficult melanocytic lesions
▸ Dysplastic Naevus Syndrome
▸ Lentigo Maligna
▸ Amelanotic Melanoma
▸ Nail pigmentation
▸ Mucosal pigmentation
▸ Complex skin cancer, including Merkel cell carcinoma,
cutaneous lymphoma, locally advanced keratinocytic carcinomas
Subspecialty and multidisciplinary clinics
▸ Acral Melanoma
▸ Lentigo Maligna
▸ High risk and extreme high risk clinics
▸ Minor procedures
▸ Pregnancy – pigmented lesions and pregnancy rashes
▸ Genetic melanoma and Genodermatoses
▸ Chemotherapy rashes
▸ Cutaneous complications of chemotherapy, including novel targeted and immunotherapies
In addition to regular multidisciplinary clinics involving dermatologists, surgeons and oncologists, we participate in the Melanoma Institute Australia weekly multidisciplinary team meetings for clinico-pathological correlation and expert consensus.
Non-invasive diagnostic technology
Early diagnosis of melanoma is key to survival. However distinguishing early melanoma from common benign skin lesions can be challenging. We are at the forefront of medical research in early melanoma diagnosis.
▸ Confocal Microscopy
▸ Optical Coherence Tomography
▸ Advanced Dermoscopy
▸ Specialised Medical Photography
Our use of non-invasive diagnostic technology promotes early diagnosis of melanoma, while minimizing unnecessary surgical procedures and biopsies. Our benign to malignant ratios are between 2:1 and 5:1, contrasting with non-specialist services for which rates of benign excisions are considerably higher.
Where appropriate, we prescribe non-invasive topical therapies for skin cancer management, supervised by our team of expert registered nurses.
Through our multidisciplinary meetings, we have access to prescription of specialist therapies for locally advanced and inoperable BCCs and SCCs.